Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
As a multifactorial and multiorgan syndrome, cancer cachexia is associated with decreased tolerance to antitumor treatments and increased morbidity and mortality rates. The current approaches for the treatment of this syndrome are not always effective and well established. Drug repurposing or reposi...
Guardado en:
Autores principales: | Joana M. O. Santos, Alexandra C. Costa, Tânia R. Dias, Setareh Satari, Maria Paula Costa e Silva, Rui M. Gil da Costa, Rui Medeiros |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6d4ed0b4f014da6a9ec9e7f517439e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks
por: Mapopa Chipofya, et al.
Publicado: (2021) -
Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study
por: Angela Bonaccorso, et al.
Publicado: (2021) -
Drug repurposing for tooth regeneration: The promising premises
por: T C Divya, et al.
Publicado: (2021) -
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
por: Joelle C. Boulos, et al.
Publicado: (2021) -
A 5 year retrospective analysis of adverse drug reactions associated with antimicrobials in a teaching hospital of Andaman and Nicobar islands
por: Mangesh Bankar, et al.
Publicado: (2021)